Pharmaceutical companies are fueling the rise of superbugs by manufacturing drugs in factories that leak industrial waste, says a new report (Drug Resistance through the Back Door – How the Pharmaceutical Industry is Fuelling the Rise of Superbugs through Pollution in its Supply Chains) which calls on them to radically improve their supply chains. Read more “How Big Pharma’s Industrial Waste is Fueling the Rise in Superbugs Worldwide”
The history of medicine is like a roller-coaster ride. First, they used herbs. Then they discovered electrotherapy.
Having fully appreciated the full potential of electrotherapy in eliminating ailments at its root cause, they resorted to chemical drugs of the medieval period due to its low production cost and its effectiveness in masking the symptoms that keeps the customers coming back.
Now that more superbugs are being discovered, how should the mainstream medicine industry respond if its drug-based approach is rendered moot and obsolete?
A very strong case is being forwarded against the continued use of chemical drugs to fight against bacteria that have evolved into superbugs or antibiotic resistant bacteria. Both, the US Center for Disease Control and the World Health Organization, have considered antibiotic resistance a global threat and the next pandemic.
Antibiotic-resistant genes, that evolved in the crowded atmosphere of Texas commercial cattle ranches, have gone airborne and are now capable of “travelling for long distances.”